Patent · US Active

Use of vanadium compounds to accelerate bone healing

US9730946B2 · kind B2 · utility

4Cited by

11References

13Claims

0Family size

Assignee

Rutgers, the State University of New Jersey · US

Inventors

Sheldon S. Lin · Chatham, US
David N. Paglia · Meridian Avenue, US
James P. O'Connor · Menlo Park, US
Eric Breitbart · South Orange, US
Joseph Benevenia · Montclair, US

Key dates

Filing date	Dec 10, 2014
Grant date	Aug 15, 2017
Priority date	—
Expiry date	Dec 10, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61L2430/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention provides a method of promoting bone healing by locally administering a vanadium-based insulin mimetic agent to a patient in need thereof. The invention also provides a new use of insulin-mimetic vanadium compounds for manufacture of medicaments for accelerating bone-healing processes. In addition, the invention also encompasses a bone injury treatment kit suitable for localized administration of insulin-mimetic vanadium compounds or compositions thereof to a patient in need of such treatment.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.